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PKA Phosphorylation of Src Mediates
cAMP’s Inhibition of Cell Growth via Rap1
nonneuronal cells, including NIH3T3 cells (Schmitt and
Stork, 2001), Rat-1 fibroblasts (Burgering et al., 1993;
Cook and McCormick, 1993; Wu et al., 1993), myocytes
John M. Schmitt and Philip J.S. Stork1
Vollum Institute and
Department of Cell and Developmental Biology
Oregon Health Sciences University (Graves et al., 1993), adipocytes (Sevetson et al., 1993),
and others. cAMP blocks growth factor activation ofPortland, Oregon 97201
ERK by blocking the ability of the small G protein Ras
to activate the MAP kinase Raf-1 (Cook and McCormick,
1993). Early studies proposed that PKA phosphorylationSummary
of Raf-1 uncoupled Raf-1 from Ras (Wu et al., 1993);
however, this has been recently debated (Sidovar et al.,In fibroblast cells, cAMP antagonizes growth factor
activation of ERKs and cell growth via PKA and the 2000).
One candidate mediating cAMP’s inhibition of Raf-1small G protein Rap1. We demonstrate here that PKA’s
activation of Rap1 was mediated by the Rap1 guanine and ERKs is the small G protein, Rap1 (Dugan et al.,
1999; Schmitt and Stork, 2001). Rap1 is a ubiquitouslynucleotide exchange factor C3G, the adaptor Crk-L,
the scaffold protein Cbl, and the tyrosine kinase Src. expressed small GTP binding protein that is activated
by cAMP (Altschuler et al., 1995). It was first identifiedSrc was required for cAMP activation of Rap1 and the
inhibition of ERKs and cell growth. PKA activated Src in NIH3T3 cells for its ability to antagonize mitogenic
signals (Kitayama et al., 1989) and was subsequentlyboth in vitro and in vivo by phosphorylating Src on
serine 17 within its amino terminus. This phosphoryla- shown to block Ras-dependent activation of Raf-1 (Cook
et al., 1993). Depending on the cell type, Rap1, liketion was required for cAMP’s activation of Src and
Rap1, as well as cAMP’s inhibition of ERKs and cell cAMP, can either activate or inhibit ERKs (Dugan et al.,
1999; Vossler et al., 1997). In cells where cAMP activatesproliferation. This study identifies an antiproliferative
role for Src in the physiological regulation of cell ERKs, Rap1 has been shown to be required for this
activation (Dugan et al., 1999; Vossler et al., 1997; Wangrowth by cAMP.
and Huang, 1998). In NIH3T3 cells where cAMP inhibits
ERKs, Rap1 mediates this effect as well (Schmitt andIntroduction
Stork, 2001). Despite abundant literature on cAMP’s
ability to activate Rap1 (Altschuler et al., 1995; de RooijHormones linked to cAMP have displayed well-studied
effects on cell growth and differentiation (Dhanasekaran et al., 1998; Dugan et al., 1999; Tsygankova et al., 2001;
Vossler et al., 1997; Wan and Huang, 1998), the mecha-et al., 1995). The antiproliferative action of cAMP has
been well studied largely in conjunction with hormone nism of cAMP’s activation of Rap1 is unknown.
One direct link between cAMP and Rap1 came withreceptors linked to Gs, adenylyl cyclase, and the activa-
tion of the cyclic AMP-dependent protein kinase PKA. the discovery of Rap1-specific guanine nucleotide ex-
change factors (GEFs) that are themselves activated byFor example, hormones such as epinephrine, norepi-
nephrine, prostaglandins, adenosine, VIP, glucagon, direct binding of cAMP (de Rooij et al., 1998). However,
in many cell types, Rap1 activation by cAMP requiresand parathyroid hormone inhibit the proliferation of a
diverse group of cells and tissues, including myocytes PKA (Dugan et al., 1999; Grewal et al., 2000; Schmitt
and Stork, 2000, 2001; Vossler et al., 1997; Wan and(Graves et al., 1993), adipocytes (Sevetson et al., 1993),
fibroblasts (Burgering et al., 1993; Wu et al., 1993), glial Huang, 1998), and it is possible that cAMP-GEFs acti-
vate small G proteins other than Rap1. Many other po-cells (Dugan et al., 1999), and lymphocytes (Tamir et al.,
1996) via the stimulation of cAMP synthesis and PKA. tential Rap1 exchangers have been identified including
C3G and CalDag-GEF (Bos et al., 2001) for which neitherOne important feature of cAMP’s growth effects is its
cell-type specificity (Burgering et al., 1993). For exam- their regulation by cAMP nor their physiological roles
have been examined fully. In this study, we examined theple, oncogenic Gsp mutations that lead to constitutively
activated Gs and elevated cAMP levels are mitogenic mechanism by which cAMP activates Rap1 in fibroblast
cells.when introduced into Swiss 3T3 cells (Zachary et al.,
1990) but are antiproliferative when introduced into
NIH3T3 fibroblast cells (Chen and Iyengar, 1994). This Results
cell-type specificity can be explained by cAMP’s cell-
type-specific regulation of the extracellular signal-regu- cAMP/PKA Activation of Rap1 Requires C3G
lated kinase (ERK) (Burgering et al., 1993; Schmitt and Forskolin is a potent activator of adenylyl cyclases and
Stork, 2001; Vossler et al., 1997). ERK is a critical regula- rapidly elevates intracellular cAMP levels. Forskolin’s
tor of cell growth and mediates the mitogenic effects of activation of endogenous Rap1 in NIH3T3 cells is
many growth factors (Graves et al., 2000). cAMP acti- blocked by pretreatment of cells with H89, a selective
vates ERKs in many neuronal and endocrine cells (Du- inhibitor of PKA (Chijiwa et al., 1990), as well as the
gan et al., 1999; Grewal et al., 1999; Vossler et al., 1997). protein kinase inhibitor of PKA, PKI (Schmitt and Stork,
In contrast, cAMP inhibits ERK activation in a variety of 2001), demonstrating that cAMP’s activation of Rap1
required PKA in these cells.
PKA phosphorylates Rap1 directly (Altschuler et al.,1Correspondence: stork@ohsu.edu
Figure 1. PKA Stimulation of Rap1 Activity
Occurs via Stimulation of Membrane-Associ-
ated C3G, Crk, and Cbl
(A) PKA’s activation of Rap1 is indirect. Sepa-
rate plates of NIH3T3 cells were either trans-
fected with Flag-Rap1 or stimulated with For-
skolin. Forskolin-treated cells received either
a pretreatment (pre-tx) or posttreatment
(post-tx) with H89. Flag-Rap1 lysates were
incubated with treated lysates and analyzed
for Flag-Rap1 activation (Flag-Rap1-GTP).
Flag-Rap1 levels are shown in the lower
panel.
(B) PKA activates Rap1 via a membrane-
associated protein. Separate plates of NIH3T3
cells were treated as in Figure 1A. Forskolin-
treated cells received a pretreatment (pre-tx)
with H89. The cytosolic (C) or membrane (M)
fractions from treated lysates were prepared
and incubated with Flag-Rap1 lysates and
analyzed for Flag-Rap1 activation as in (A).
(C) C3G is necessary for Rap1 activation by
PKA. Membranes of lysates from untreated
or Forskolin-treated NIH3T3 cells were incu-
bated with the immunoprecipitating antibod-
ies C3G, SOS, or ERK2, as indicated, and the
remaining supernatant (supe) analyzed for
the presence of C3G by Western blot (top
panel). The membrane supernatant was then
incubated with lysates from Flag-Rap1-trans-
fected cells and analyzed for Flag-Rap1 acti-
vation (lower panel, Flag-Rap1-GTP) as in (A).
(D) Forskolin stimulation recruits C3G into
membranes. NIH3T3 cells were left untreated or stimulated with Forskolin in the presence or absence of H89. Membranes were then analyzed
for C3G by Western blot (upper panel). Total cell lysates were also examined for the presence of C3G (lower panel).
(E) Forskolin stimulates Cbl tyrosine phosphorylation in a PKA- and Src-dependent manner. NIH3T3 cells were treated with Forskolin in the
presence or absence of H89 or PP2, and endogenous Cbl was immunoprecipitated from cell lysates and analyzed by Western blot for tyrosine
phosphorylation (pTyr). Total cell lysates were also examined for endogenous Cbl by Western blot (Cbl) (lower panel).
(F) C3G, Crk-L, and Cbl form a complex following Forskolin treatment of NIH3T3 cells. Cells were left untreated or stimulated with Forskolin,
PDGF, or EGF. Myc-Cbl was immunoprecipitated from cells and the pellets analyzed by Western blot using antibodies specific for Crk-L and
C3G (middle and upper panels, respectively). Total cell lysates were examined for myc-Cbl by Western blot using a myc antibody (lower
panel).
1995; Vossler et al., 1997), but the consequences of this ies to C3G, but not control antibodies, eliminated C3G
from the membrane (supe; upper panel). Membranesphosphorylation are not clear (Hu et al., 1999; Tsygan-
kova et al., 2001). To test the possibility that PKA acti- immunodepleted of C3G could no longer activate Rap1
in trans (Figure 1C, lower panels), whereas immunode-vates Rap1 by phosphorylating proteins lying upstream
of Rap1, we examined the ability of lysates from For- pletion of the related Ras exchanger, SOS, did not block
Forskolin’s effects. Immunodepletion of ERK2 servedskolin-treated cells to activate Rap1 in trans. Lysates
from Forskolin-treated cells retained the ability to acti- as a negative control.
C3G is recruited to membranes upon its activationvate Flag-Rap1 expressed in untreated cells (Figure 1A),
and this activation in trans was blocked by pretreatment (Tanaka et al., 1994). As shown in Figure 1D, C3G rapidly
moved into the membranes following Forskolin stimula-with H89, confirming a role for PKA.
To test whether PKA was required to activate Flag- tion, and this required PKA. Taken together, these data
demonstrate that PKA activation of Rap1 was indirectRap1 directly, we added H89 10 min after the addition
of Forskolin to permit PKA-dependent phosphorylation and required the membrane-associated Rap1 GEF, C3G.
of substrates to occur prior to mixing of Forskolin-
treated and untreated Flag-Rap1-expressing lysates. In- cAMP/PKA Activation of Rap1 Requires
Crk-L, Cbl, and Srcterestingly, lysates from these cells were still able to
activate Flag-Rap1 in trans (Figure 1A). Since this proto- C3G exists in the cytoplasm in a complex with a member
of the Crk family of small adaptor molecules includingcol ensures that PKA cannot phosphorylate Flag-Rap1
directly, these results demonstrate that PKA can acti- Crk-L, Crk-I, and CrkII (Knudsen et al., 1994; Tanaka et
al., 1994). Upon stimulation by growth factors, the Crk/vate Rap1 via proteins upstream of Rap1.
Only the membrane fraction of Forskolin-treated C3G complex is thought to be recruited to the membrane
where it binds to scaffolding molecules including IRS-1NIH3T3 cells could activate Rap1 in trans, and this re-
quired PKA (Figure 1B). Previous studies have sug- (Sorokin et al., 1998) and Cbl (Xing et al., 2000) via tyro-
sine phosphorylations that bind Crk’s SH2 domain.gested that the Rap1-GEF, C3G, might be involved in
cAMP activation of Rap1 (Schmitt and Stork, 2000). In IRS-1 is not tyrosine phosphorylated by Forskolin in
NIH3T3 cells (Calleja et al., 1997). Surprisingly, endoge-Figure 1C, we show that immunodepletion with antibod-
Figure 2. cAMP Activation of Rap1 and Inhibition of ERKs Occurs via C3G, Crk-L, Cbl, and Src Family Kinases in NIH3T3 Cells
(A) Crk, Cbl, and Src are required for Rap1 activation by cAMP. NIH3T3 cells were transfected with Flag-Rap1 along with d.n.Src, Cbl-ct, and
CBR and left untreated or stimulated with Forskolin. Lysates were then analyzed for Flag-Rap1 activation. The lower panel is a Western blot
control for levels of Flag-Rap1 expression.
(B) c.a.Src activates Rap1 via Crk and Cbl. Flag-Rap1 was cotransfected with c.a.Src into NIH3T3 cells along with CBR and Cbl-ct. Cell lysates
were then analyzed for Flag-Rap1 activation as in (A).
(C) Isoproterenol activates endogenous Rap1 via PKA and SFKs. Cells were left untreated or treated with isoproterenol in the presence or
absence of either H89 or PP2. Lysates were then analyzed for activation of endogenous Rap1 (Rap1-GTP) or total Rap1 levels.
(D) C3G, Crk, Cbl, and SFKs mediate cAMP-stimulated Rap-1 association with Raf-1. NIH3T3 cells were transfected with His-Rap1 along with
either CBR or Cbl-ct. Cells were left untreated or stimulated with Forskolin, as indicated. His-Rap1-containing eluates were analyzed by
Western blot for the presence of Raf-1 (top panel) and His-Rap1 (lower panel).
(E) SFKs and PKA are necessary for cAMP’s ability to inhibit EGF-mediated activation of ERKs in NIH3T3 cells. Cells were treated with
Forskolin or EGF, in the presence or absence of either H89 or PP2. Cell lysates were analyzed by Western blot for phosphorylation of
endogenous ERK1/2 (pERK, top panel) or total ERK2 (bottom panel).
(F) SFKs and PKA are necessary for cAMP’s ability to inhibit PDGF-mediated activation of ERKs in NIH3T3 cells. Cells were left untreated or
treated with Forskolin and/or PDGF, as indicated, in the presence or absence of PP2. Cell lysates were analyzed by Western blot as in (E).
nous Cbl was tyrosine phosphorylated following For- skolin was blocked by each interfering mutant (Figure
2A). Transfection of constitutively active Src (SrcY527F,skolin stimulation of these cells (Figure 1E). This phos-
phorylation was inhibited by either H89 or PP2, a or c.a.Src) activated Rap1. This required both C3G/Crk
as well as Cbl (Figure 2B). Thus, cAMP’s activation ofselective inhibitor of Src family kinases (SFKs) (Hanke
et al., 1996), suggesting that both PKA and SFKs are Rap1 involves the recruitment of C3G/Crk to a mem-
brane-associated complex with Cbl, and Src is bothrequired for this effect (Figure 1E). Forskolin treatment
of NIH3T3 cells stimulated the formation of a complex necessary and sufficient for this action. In addition, both
isoproterenol and prostaglandin PGE1 activated Rap1containing C3G, Crk-L, and Cbl (Figure 1F), which was
also blocked by both H89 and PP2 (data not shown). in NIH3T3 cells via PKA and SFKs (Figure 2C, and data
not shown). These data demonstrate that Forskolin andInterestingly, neither PDGF nor EGF stimulated the for-
mation of this complex (Figure 1F). hormonal elevation of cAMP use similar mechanisms to
activate Rap1.To investigate whether this Cbl/Crk/C3G complex was
required for Rap1 activation by PKA, we transfected
NIH3T3 cells with Flag-Rap1 and one of the following PKA’s Inhibition of ERKs and Cell Proliferation
Requires Srcmutants: CBR, a truncated form of C3G which interferes
with Crk function; Cbl-ct; a carboxy-terminal fragment In NIH3T3 cells, a consequence of cAMP/PKA activation
of Rap1 is the association of Rap1 and Raf-1 (Schmittof Cbl that blocks Cbl function; or a kinase-dead Src
mutant (SrcK296R, or d.n.Src). Rap1 activation by For- and Stork, 2001). We show that this association was
Figure 3. Inhibition of Growth Factor-Medi-
ated Activation of ERKs and Cell Proliferation
by cAMP Requires Src Kinase
(A) Src kinase is necessary for Forskolin’s ac-
tivation of Rap1 and inhibition of ERKs in Fi-
broblasts. Src or SYF cells were untreated
or stimulated with Forskolin and/or PDGF, as
indicated. Lysates were analyzed by Western
blot for activation of endogenous ERK1/2
(pERK, top panel), Rap1 (Rap1-GTP, bottom
panel), or total ERKs (ERK2, middle panel).
(B) Wild-type Src restores the ability of cAMP
to inhibit ERKs in SYF cells. Cells were trans-
fected with the indicated cDNAs and stimu-
lated as in (A). Lysates were analyzed by
Western blot for phosphorylation of myc-
ERK2 (pmyc-ERK2, top panel) and total
ERK2.
(C) cAMP activates Rap1 in SYF cells that
have been transfected with wild-type Src.
SYF cells were transfected with Flag-Rap1
and Flag-Src as indicated and stimulated with
Forskolin in the presence or absence of H89
or PP2 and examined for Flag-Rap1 acti-
vation.
(D) Only Src can reconstitute cAMP activation
of Rap1 in SYF cells. SYF cells were trans-
fected with Flag-Rap1 and cDNAs encoding
wild-type Src, Yes, Fyn, or Lck and stimulated
with Forskolin. Cell lysates were examined as
in (C).
(E) Tyrosine phosphorylation of endogenous
Cbl by cAMP stimulation is rescued by Src.
Srcor SYF cells were treated with Forskolin
in the presence or absence of H89 or PP2.
Endogenous Cbl was immunoprecipitated
from cell lysates and analyzed by Western
blot for tyrosine phosphorylation of Cbl (pTyr,
top panel) or total Cbl protein (Cbl, bottom
panel).
(F) Reconstitution of SYF cells with wild-type Src restores Cbl tyrosine phosphorylation. Fibroblasts were transfected with myc-Cbl and Src,
as indicated, and as in (E). Myc-Cbl was immunoprecipitated from cell lysates and examined by Western blot for either tyrosine phosphorylation
(pTyr, upper panel), or myc-Cbl (bottom panel).
(G) cAMP stimulation blocks growth factor-stimulated cell growth in Src cells. Fibroblasts were treated with PDGF, EGF, Forskolin, H89,
and/or PD98059 (PD), as indicated. Cells were analyzed 48 hr later by MTT assay (see Experimental Procedures) and data was quantified
(n  4  SE).
(H) cAMP’s inhibition of cell growth by PDGF and EGF is prevented in cells lacking Src kinase. Cells were treated and analyzed as in (G) (n 
4  SE).
blocked by CBR, Cbl-ct, and PP2 (Figure 2D) suggesting not activate Rap1 in SYF cells (Figure 3A, lower panel).
Activation of Rap1 and inhibition of ERKs occurred inthat sequestration of Raf-1 by Rap1, as well as Rap1
activation itself, required C3G, Crk, Cbl, and SFKs. Next, cAMP-treated SYF cells that were transfected with wild-
type Flag-Src (Figures 3B and 3C). Taken together, thesewe investigated the requirement of SFKs in cAMP’s an-
tagonism of ERK activation. Inhibition of SFKs had no results demonstrate that Src mediated cAMP’s inhibition
of ERK via Rap1 activation. This action of Src was noteffect on either EGF’s or PDGF’s activation of ERKs,
but prevented Forskolin’s inhibition of ERKs (Figures 2E shared by related members of the SFK family including
Yes, Fyn, and Lck (Figure 3D), suggesting that this actionand 2F).
To directly examine the role of Src in cAMP’s activa- of Src was unique among SFKs.
Forskolin stimulated the tyrosine phosphorylation oftion of Rap1, we used mouse embryonic fibroblasts in
which the genes encoding Src, Yes, and Fyn (SYF) or Cbl in a PKA- and Src-dependent fashion in Src cells
(Figure 3E), as well as SYF cells reconstituted with Flag-in which only Yes and Fyn (Src) have been ablated
(Klinghoffer et al., 1999). PDGF stimulation of ERKs and Src (Figure 3F), but not in untransfected SYF cells (Figure
3E), suggesting that Src was required for the PKA-depen-proliferation does not require Src family kinases in SYF
cells (Klinghoffer et al., 1999); therefore, this model sys- dent phosphorylation of Cbl in mouse embryonic fibro-
blasts.tem is well suited to examine Src’s potential antiprolifer-
ative role in cAMP signaling. As expected, cAMP was PDGF and EGF stimulation of proliferation in both
Src and SYF cells was blocked by the selective MEKable to inhibit PDGF-mediated ERK activation in Src
cells, but not in SYF cells (Figure 3A). Moreover, although inhibitor PD98059 (Figures 3G and 3H) (Schmitt and
Stork, 2001). Forskolin treatment completely inhibitedcAMP robustly activated Rap1 in Src cells, cAMP did
Figure 4. Src Is Activated Following Phos-
phorylation of Ser17 by PKA In Vivo
(A) Endogenous Src is activated by cAMP/
PKA in Src cells. Src cells were treated
with Forskolin in the presence or absence of
H89 or PP2 as indicated. Src was immunopre-
cipitated from cell lysates and analyzed by
Western blot for either tyrosine phosphoryla-
tion at residue 416 (p416Src, upper panel) or
Src (bottom panel).
(B) Exogenous Src is activated by cAMP/PKA
in SYF cells. SYF cells were transfected with
wild-type Flag-Src and treated similarly to (A).
Flag-Src was immunoprecipitated from cell ly-
sates and analyzed by Western blot as in (A).
(C) Forskolin stimulates Src/Cbl association
via PKA. SYF cells were transfected with wild-
type Flag-Src and treated similarly to (A).
Flag-Src was immunoprecipitated from cell
lysates and analyzed by Western blot for ei-
ther Cbl (upper panel) or Flag-Src (bottom
panel).
(D) PKA stimulates phosphorylation of endogenous Src in vivo. Src cells were treated identically to (A). Src was immunoprecipitated from
cell lysates and analyzed by Western blot for either PKA phosphorylation (Src phosphorylation, upper panel) or Src (bottom panel).
this response in a PKA-dependent manner in Src cells PKA recognition motif (Figure 5A). These studies verify
the utility of this antibody for these and subsequent(Figure 3G), but not in SYF cells (Figure 3H), demonstra-
ting a requirement for Src in cAMP’s antiproliferative studies.
Following transfection and Forskolin treatment of SYFactions.
cells, we detected phosphorylation of wild-type Src but
not a Src protein that had its serine at residue 17 substi-PKA Phosphorylation of Src at Serine 17
tuted by an alanine (Flag-SrcS17A) (Figure 5B), confirm-To examine the mechanism of cAMP regulation of Src,
ing that Ser17 was the major PKA phosphorylation siteSrc kinase activity was assayed in vivo by monitoring
located within Src that was recognized by this antibody,the autophosphorylation of Src itself on tyrosine 416
consistent with the findings of Erickson (Collett et al.,(Brown and Cooper, 1996). Forskolin stimulated phos-
1979) and Hanafusa (Cross and Hanafusa, 1983). Wephorylation of tyrosine 416 in both endogenous Src (Fig-
propose that Src is primarily phosphorylated both inure 4A) and transfected Flag-Src (Figure 4B). This re-
vitro and in vivo at Ser17 by PKA, but not by EGF orquired both PKA and Src (Figures 4A and 4B). Forskolin
PDGF (Figure 5B).treatment induced an association between Src and Cbl
The activation of wild-type Src, but not SrcS17A, byin Flag-Src-transfected SYF cells (Figure 4C), which was
Forskolin was confirmed by autophosphorylation of Srcalso dependent on PKA and Src (Figures 4A–4C). These
at 416 (Figure 5C) and in vitro kinase (Figure 5D). Inter-data suggest that PKA stimulates Src kinase activity
estingly, a Src mutant containing aspartate at positionand phosphorylation of an endogenous substrate, Cbl
17 (SrcS17D) showed elevated kinase activity (Figure(Thien and Langdon, 2001).
5D) and constitutive phosphorylation on tyrosine 416Src contains one consensus PKA site at serine 17
that was not further increased by Forskolin treatment(Ser17) within its amino terminus that represents the
(Figure 5E), constitutive Rap1 activation (Figure 5F), amajor site of serine phosphorylation within Src (Brown
complete block of ERK activation in response to PDGFand Cooper, 1996; Cross and Hanafusa, 1983; Roth et
(Figure 5G), and an inhibition of growth factor activational., 1983). To confirm this finding, we used an antibody
of cell proliferation (Figure 5H). This is consistent withdesigned to recognize substrates phosphorylated by
the mutant aspartate residue mimicking serine phos-PKA (provided by Cell Signaling, Beverly, MA). This anti-
phorylation at this site. Importantly, EGF as well as PDGFbody recognizes phospho-serine/threonine residues that
activated both wild-type Src and SrcS17A equally (Fig-are preceded by arginine at the 3 position (RXXpS/T),
ure 5C). Moreover, both SrcS17A and wild-type Src po-comprising the recognition site of PKA. Indeed, the abil-
tentiated PDGF stimulation of cellular proliferation toity of this antibody to recognize Src protein was in-
the same degree (Figure 5H). These data demonstratecreased by Forskolin treatment in a manner that required
that the SrcS17A mutant retained proper protein foldingkinase activity of PKA (but not Src) (Figure 4D). Using
for activation of catalytic activity by growth factors andthis antibody, we examined the ability of PKA to phos-
functioned in growth factor signaling pathways.phorylate Ser17 directly. Peptide fragments containing
the N-terminal 9–25 amino acids of wild-type Src (WT)
were phosphorylated in vitro by the catalytic subunit of Ser17 Phosphorylation and Activation of Src
Is Required for Rap1 ActivationPKA. Control peptides were also included (Figure 5A).
Only the peptides containing Ser17 and adjacent argi- and ERK Inhibition by PKA
Only wild-type Src, but not SrcS17A, reconstituted For-nines (WT and S12A) were recognized by the antibody,
consistent with the phosphorylation of the consensus skolin’s activation of Rap1 in these cells (Figure 6A),
Figure 5. PKA Phosphorylates Src on Ser17
In Vitro and In Vivo
(A) PKA directly phosphorylates Ser17 of Src
in vitro. N-terminal Src peptides (whose se-
quences are indicated in the figure) were in-
cubated with the catalytic subunit of PKA and
examined for PKA phosphorylation using the
phospho-PKA substrate antibody.
(B) PKA phosphorylates wild-type Src but not
SrcS17A in vivo. SYF cells were transfected
with either Flag-Src or Flag-SrcS17A and
stimulated with Forskolin or PDGF or EGF as
indicated. Flag-Src was immunoprecipitated
from cell lysates and analyzed by Western
blot for either PKA phosphorylation of Src
(phospho-Src (phospho-PKA Ab), upper panel)
or the presence of Flag-Src (bottom panel).
(C) Forskolin activates wild-type Src but not
SrcS17A in SYF cells. Cells were transfected
with either Flag-Src or Flag-SrcS17A and
treated identically to (B). Flag-Src was immu-
noprecipitated from cell lysates and analyzed
by Western blot for either phosphorylation of
Src on tyrosine 416 (pSrc416, upper panel) or
the presence of Flag-Src (bottom panel).
(D) cAMP stimulates tyrosine kinase activity
of wild-type Src protein, but not the SrcS17A
mutant. SYF cells were transfected with Flag
Src, Flag-SrcS17A, or Flag-SrcS17D and
treated with Forskolin as indicated. Kinase
activity was assayed following Flag immuno-
precipitation (n  3  SD).
(E) SrcS17D displays constitutive phosphory-
lation of 416. SYF cells were transfected with
either Flag-Src (WT) or Flag-SrcS17D(S17D)
and treated with Forskolin as indicated. Pro-
teins were immunoprecipitated from cells and
analyzed as in (C).
(F) SrcS17D induces constitutive activation of
Rap1. SYF cells were transfected with Flag-
Rap1 and either pcDNA3 vector DNA (V) or
Flag-Src (WT) and treated with Forskolin or
transfected with Flag-SrcS17D (S17D) as in-
dicated. Lysates were then analyzed for Rap1
activation (Flag-Rap1-GTP) or Flag-con-
taining proteins (Flag-Src and Flag-Rap1).
(G) SrcS17D inhibits PDGF activation of ERKs. SYF cells were transfected with mycERK2 and either vector DNA (V), Flag-Src (WT), or Flag-
SrcS17D (S17D) and treated with PDGF plus or minus Forskolin, as indicated, and analyzed by Western blot for ERK phosphorylation (pmyc-
ERK2, upper panel) or myc (myc-ERK2, lower panel), following myc I.P.
(H) SrcS17D inhibits PDGF-mediated cell growth. SYF cells were transfected with either pcDNA3 (Vector), Flag-Src, Flag-SrcS17A, or Flag-
SrcS17D, positively selected, and treated with Forskolin and/or PDGF. Cells were analyzed 48 hr later by MTT assay and data quantified (n 
4  SE).
suggesting that PKA phosphorylation of Ser17 on Src phosphorylation of this site is required for cAMP’s ability
to activate both Src and Rap1 as well as to antagonizewas required for Rap1 activation. Interestingly, expres-
sion of SrcS17A interfered with the function of endoge- growth factor signaling to both ERKs and cell growth.
nous Src to mediate Forskolin’s stimulation of Rap1 in
Src cells (Figure 6B). As in NIH3T3 cells, d.n.Src, Cbl-
ct, and CBR also blocked Forskolin’s actions in Src Discussion
cells (Figure 6B). Next, we examined the role of Ser17
in Forskolin’s ability to inhibit PDGF’s activation of ERK. PKA Phosphorylation of Src
In 1978, Erickson and colleagues demonstrated an in-Again, only wild-type Src, but not Src17A, restored For-
skolin’s inhibition of ERK in SYF cells (Figure 6C). crease in phospho-serine within Src’s amino terminus
following treatment with cAMP (Collett et al., 1979), andPDGF and EGF both stimulated SYF cell growth in an
ERK-dependent manner that was blocked by PD98059 a consensus PKA site at Ser17 was identified (Cross and
Hanafusa, 1983). Although cAMP increased the kinase(Figure 6D). Expression of wild-type Src, but not
SrcS17A, in SYF cells restored Forskolin’s ability to in- activity of Src (Roth et al., 1983), no physiological role
for phosphorylation at Ser17 has since been proposedhibit PDGF- and EGF-mediated cell growth (Figure 6D).
Taken together, we have shown that phosphorylation (Brown and Cooper, 1996), perhaps because of the fo-
cus on Src’s proliferative functions at that time.of Ser17 of Src is a primary target of PKA and that
Figure 6. PKA Activation of Rap1 and Inhibition of ERKs and Cell Growth Require Ser17 of Src in Fibroblasts
(A) PKA activation of Rap1 in vivo requires Src phosphorylation at Ser17. SYF cells were transfected with either vector (V), Flag-Src (WT), or
Flag-SrcS17A (S17A) along with Flag-Rap1 and stimulated with Forskolin. Cell lysates were examined for Rap1 activation (Flag-Rap1-GTP,
upper panel) or Flag-containing proteins (lower panel).
(B) Flag-SrcS17A interferes with PKA’s activation of Rap1 in Src cells. SYF cells were transfected with CBR, Cbl-ct, d.n.Src, and SrcS17A
along with Flag-Rap1 and stimulated with Forskolin. Cell lysates were examined similarly to (A).
(C) PKA’s inhibition of ERKs requires Src phosphorylation at Ser17. SYF cells were transfected with either vector (V), Flag-Src (WT), or Flag-
SrcS17A (S17A) along with myc-ERK2 and stimulated with Forskolin and PDGF, alone or in combination, and analyzed by Western blot for
ERK phosphorylation (pmyc-ERK2, upper panel) or myc (myc-ERK2, lower panel), following myc I.P.
(D) cAMP’s inhibition of cell growth requires Src phosphorylation at Ser17 in SYF cells. SYF cells were transfected with either Flag-Src or
Flag-SrcS17A, and transfected cells were positively selected. Fibroblasts were treated with Forskolin, PDGF, and/or EGF alone or following
pretreatment with PD98059 (PD) or H89. Cells were analyzed 48 hr later by MTT assay and data was quantified (n  4  SE)
Src Kinase in G Protein Signaling Src-dependent assembly of Crk/C3G that functions to
activate Rap1 (Xing et al., 2000). In lymphocytes, CblSrc has been implicated in hormonal signaling via other
GPCR-linked pathways to activate the MAP kinase cas- phosphorylation and Crk/C3G recruitment correlate with
the activation of the SFK Fyn (Boussiotis et al., 1997).cade. For example, studies examining -adrenergic re-
ceptor signaling to ERKs have identified a requirement The studies presented here are consistent with previous
reports defining Cbl as a negative regulator of ERKs andfor Src downstream of G  in the activation of Ras
(Daaka et al., 1997). The requirement for PKA in the cell growth (Thien and Langdon, 2001). Although Cbl-
mediated ubiquination and degradation of mitogenicactivation of Src in this pathway is distinct from other
models where adrenergic receptor or Gs can activate signaling contribute to these actions (Thien and Lang-
don, 2001), we propose that Rap1 is an additional anti-Src directly (Cao et al., 2000; Ma et al., 2000). -adrener-
gic receptors can also activate Rap1 via PKA and Src proliferative target of Cbl.
(Figure 2C). In cells expressing the Raf isoform B-Raf,
this activation of Rap1 results in ERK activation (Schmitt
Antiproliferative Actions of Src
and Stork, 2000). In many other cells that express B-Raf,
Physiological roles for c-Src in nonproliferative func-
cAMP activation of Rap1 can activate ERKs (Chen et
tions such as cell motility, differentiation (D’Arcangelo
al., 1999; Vossler et al., 1997). It is possible that Src may
and Halegoua, 1993), and adhesion are now well estab-
be important for both Rap1 and ERK activation in cells
lished (Thomas and Brugge, 1997). However, defining its
where PKA can activate ERKs.
role in growth factor signaling has been more complex.
SFKs have been shown to be important in mitogenesis
by some (Boney et al., 2001; Broome and Hunter, 1996)Cbl/C3G/Crk in Src Signaling
Src activation of Cbl/Crk/C3G can be triggered by path- but not all growth factors (Roche et al., 1995). It is possi-
ble that in some cells Src can exert antiproliferativeways other than those initiated by cAMP/PKA. Overex-
pression studies examining the activation of Src via the effects downstream of cAMP, as well as proliferative
effects downstream of growth factors.proteins Sin (Src interacting protein) (Alexandropoulos
and Baltimore, 1996) and Cas (Crk-associated sub- One of the surprising conclusions of this study is that
specific modes of activation of Src can trigger distinctstrate) (Sakai et al., 1994) have also demonstrated a
Figure 7. Diagram of cAMP’s Inhibition of
ERKs and Cell Growth
Hormones binding to heptahelical GPCRs ac-
tivate Gs and adenylyl cyclase to elevate
intracellular levels of cAMP. Upon cAMP acti-
vation of PKA, PKA phosphorylates Src at
Ser17, triggering the activation/autophos-
phorylation of Src (p416). This activation of
Src results in the phosphorylation of down-
stream Src effectors, including Cbl. Cbl phos-
phorylation by Src induces the binding of the
Crk/C3G complex via the SH2 domains of
Crk, allowing C3G to activate Rap1. Upon ac-
tivation, Rap1 binds to Raf-1, sequestering it
from Ras, and preventing Ras activation of
Raf-1, MEK, and ERK despite the activation
of Ras by growth factors.
CO2. Cells were maintained in serum-free DMEM for 16 hr at 37Ceffector pathways of Src. We propose that hormonal
in 5% CO2 prior to treatment with various reagents for immunopre-activation of Src via PKA may use a distinct mechanism
cipitation assays, membrane preparations, Western blotting, andfrom that used in growth factor activation of Src. Similar
MTT assay. In all experiments, cells were treated with PDGF (100
models have been proposed examining “ligand” activa- ng/ml), EGF (100 ng/ml), Isoproterenol (10 	M), PGE1 (10 	M), or
tion of Src by both Sin and Cas, which results in Rap1, Forskolin (10 	M) for 5 min unless otherwise indicated. Where indi-
cated, cells were pretreated with Forskolin for 5 min and then stimu-but not Ras, activation (Xing et al., 2000).
lated with EGF or PDGF for 5 min. PP2 (10 	M), H89 (10 	M), andThe selective response of Src following activation by
PD98059 (10 	M) were added to cells 20 min prior to treatmentPKA may reflect the restricted activation of downstream
unless otherwise indicated.effectors, perhaps due to phosphorylation-dependent
changes in subcellular localization of Src, as previously
Western Blotting and Immunoprecipitation
proposed (Walker et al., 1993) and/or the regulation of Cell lysates and Western blotting were prepared as described
the binding of proteins that may regulate the activity of (Schmitt and Stork, 2001; Vossler et al., 1997). All Western blots
and immunoprecipitations were performed at least three times andthe Src kinase domain, as shown for other Src binding
representative gels shown.proteins (Boonyaratanakornkit et al., 2001; Ma et al.,
2000; Xing et al., 2000).
Plasmids and TransfectionsIn summary, we have demonstrated a requirement for
The wild-type Src cDNA was purchased from Upstate BiotechnologySrc in cAMP’s activation of Rap1, inhibition of ERKs, and (Lake Placid, NY). The wild-type Flag-Src construct was generated
inhibition of cell growth. These actions require PKA’s following subcloning Src into Bluescript KS (Clonetech, Palo Alto,
phosphorylation of Src on Ser17 as schematized in Fig- CA). The N-terminal half of Src was then cut with Hind III and an
internal BspHI site. The C-terminal half of Src was generated byure 7. This represents a novel example of a physiological
PCR from wild-type Src using specific primers to the sequenceregulation of Src function by PKA. More importantly, it
(sense oligo:ATGTCCCCAGAGGCCTTCCTGCAGGAG and anti-identifies a physiological role of Src in the antiprolifera-
sense oligo: TTAATTATCCTAGGTTCTCCCCGGGCTCGTACTGTGtive actions of hormones linked to increased levels of GCTCAGTGGA) and then cut with BspHI and BamHI and subcloned
intracellular cAMP. with the N-terminal fragment of Src into pcDNA3 containing a 2

C-terminal Flag. SrcS17A and Src17S-D were generated by PCR-
Experimental Procedures directed mutagenesis. Coding regions of all plasmids were se-
quenced in both directions prior to transfection. Wild-type Fyn, Lck,
Materials and Yes were provided by Andrey Shaw (Washington University, St.
Phosphorylation-specific ERK antibodies (pERK) that recognize Louis, MO) and subcloned into pcDNA3. Cbl-ct was provided by
phosphorylated ERK1 (pERK1) and ERK2 (pERK2) were purchased Brian Druker (OHSU, Portland, OR). SrcK296R (d.n.Src) was pro-
from New England Biolabs (Beverly, MA). Phospho-Src (Tyr416) and vided by Karin Rodland (OHSU, Portland, OR). NIH3T3, SYF, or Src
phospho-(Ser/Thr) PKA substrate antibodies were purchased from cells were cotransfected at 70%–80% confluency with the indicated
Cell Signaling Technology (Beverly, MA). Antibodies to Rap1, C3G, cDNAs using Lipofectamine 2000 (GIBCO-BRL). Control vector,
Cbl, Raf-1, ERK2, Src, SOS, c-myc (9E10), pTyr, and agarose-conju- pcDNA3 (Invitrogen Corp.), was included in each set of transfections
gated antibodies to myc were purchased from Santa Cruz Biotech- to normalize the amount of transfected DNA. Following transfection,
nology (Santa Cruz, CA). Flag (M2) antibody, epidermal growth factor cells were allowed to recover in serum containing media for 24
(EGF), platelet-derived growth factor (PDGF), PGE1, isoproterenol, hr. Cells were then starved overnight in serum-free DMEM before
and MTT were purchased from Sigma (St. Louis, MO). Forskolin, treatment and lysis.
PD98059, PP2, and N- [2-(p-Bromocinnamylamino) ethyl]-5-isoqui-
nolinesulfonamide (H89) were purchased from Cal Biochem (River- Src Kinase Assay
side, CA). Nickel agarose (Ni-NTA-Agarose) was purchased from SYF cells were transfected with the indicated cDNAs and left un-
Qiagen (Chatswoth, CA.). treated or stimulated with Forskolin, as indicated. Following immu-
noprecipitation and washing of Flag proteins, samples were sub-
jected to an in vitro protein tyrosine kinase assay using RR-SrcCell Culturing Conditions and Treatments
NIH3T3, SYF, and Src cells were purchased from ATCC and cul- peptide (Life Technologies-Invitrogen, Carlsbad, CA). Proteins were
reconstituted in 10 	l of buffer and incubated with 10 	l of eithertured in Dulbecco-Modified Eagle Medium (DMEM) plus 10% fetal
calf serum, penicillin/streptomycin, and L-glutamine at 37C in 5% 2
 substrate solution or 2
 control solution both containing 0.5
	Ci [-32P]ATP. The kinase reactions and analyses were carried out References
according to the manufacturer’s guidelines.
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